-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
What to Do When Two Households Become One
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
Jumia Reports Third Quarter 2026 Results
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
Devan Ekambaram and Susha’s 'Varuvaaiy' Makes History as First Tamil Song Nominated for a Grammy
-
Xreal Aura Review: A Comfortable VR Alternative With Flawed Controls
'We must change': Japan's morning-after pill debate
When Megumi Ota needed the morning-after pill in Japan, she couldn't get a prescription in time under a policy activists call an attempt to "control" women's reproductive rights.
"I wanted to take it but couldn't over a weekend," when most clinics are closed, she told AFP.
Unable to arrange an appointment in the 72 hours after sex when the drug is most effective, "I just had to leave it to chance, and got pregnant."
Emergency contraception cannot be bought without a doctor's approval in Japan and is not covered by public health insurance, so can cost up to $150.
It's also the only medicine that must be taken in front of a pharmacist to stop it being sold on the black market.
Abortion rights are just as restrictive, campaigners say, with consent required from a male partner, and a surgical procedure the only option because abortion pills are not yet legal.
A government panel was formed in October to study if the morning-after pill should be sold over the counter, like in North America, most of the EU and some Asian countries.
But gynaecologists have raised concerns, including that it could increase the spread of diseases by encouraging casual, unprotected sex.
Ota decided to terminate her pregnancy after her partner, who had refused to use condoms, reacted coldly to the news.
"I just felt helpless," said the 43-year-old, who was 36 at the time and now runs a sexual trauma support group.
Japan has world-class medical care, but is ranked 120th of 156 countries in the World Economic Forum's gender gap index, which measures health among other categories.
"In Japan's system, there's a perception that women may abuse what they have and do something wrong," said reproductive rights advocate Asuka Someya.
"There's a strong paternalistic tendency in the medical world. They want to keep women under their control."
- Limited choices -
The debate comes with reproductive rights in the global spotlight.
In the United States, the Supreme Court appears poised to overturn a 1973 ruling guaranteeing abortion access nationwide, while Poland enacted a near-total ban on terminations less than two years ago.
There are an estimated 610,000 unplanned pregnancies each year in Japan, according to a 2019 survey by Bayer and Tokyo University.
Abortion has been legal since 1948, and is available up until 22 weeks, but consent is required from a spouse or partner. Exceptions are granted only in cases of rape or domestic abuse, or if the partner is dead or missing.
A British pharmaceutical firm last year applied to Japanese health authorities for approval of its abortion pill, which can be used in early pregnancy.
But until a decision is made, those seeking a termination must undergo an operation to remove tissue from the womb with a metal or plastic instrument.
The procedure costs around 100,000 to 200,000 yen ($800 to $1,500), with late-stage abortions sometimes even more expensive.
Someya, who had an abortion as a student, said she was "terrified" and wishes she had been able to "choose more comfortably between different options".
"I was informed of the risk that the operation could leave me sterile, but I thought I would be to blame," said the 36-year-old, who now views abortion as medical care women deserve access to.
Birth control choices are also limited in Japan, where condoms are by far the preferred method and alternatives are rarely openly discussed.
Contraceptive pills were approved in 1999, after decades of deliberation by the government -- compared to just six months for Viagra.
Nowadays they are used by just 2.9 percent of women of reproductive age, compared to a third in France and nearly 20 percent in Thailand, according to a 2019 UN report.
Meanwhile IUDs, which sit inside the womb to prevent pregnancy, are used by 0.4 percent while implants and injections are not available at all.
- 'We must change' -
Gynaecologist Sakiko Enmi, a leading member of the campaign for better access to the morning-after pill, said the government must not drag its feet.
Levonorgestrel, a drug used in emergency contraception to delay or prevent ovulation, has been legal in Japan for more than a decade.
But "it does not reach those who really need it, due to poor accessibility and the price," Enmi said.
Women can consult a doctor online, but still must take the morning-after pill in front of a pharmacist -- Japan's only medicine that has this requirement as standard, the Tokyo Pharmaceutical Association says.
A previous government panel rejected making emergency contraception available over the counter in 2017, and many medics remain opposed to the change.
In October, a Japan Association of Obstetricians and Gynecologists survey found 40 percent of its members were against the proposal.
Overall, 92 percent said they had concerns, with the report stating that "this country needs to improve sex education before considering whether to make the emergency contraceptive pill available over the counter".
Enmi, however, is adamant about what needs to happen.
"We must change," she said. "Women should be allowed to make decisions for themselves."
F.Pedersen--AMWN